Value Investor
Start free

Dentsply Sirona

XRAY on Nasdaq. Dentsply Sirona sells dental equipment and supplies to dentists and healthcare providers. Market value $1.7bn.

Watch this stockFree. We tell you when something changes.

Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to December 2025.

Recent profit includes a big one-time charge, so we price the company excluding that charge.

Should I look at this?

Not a fit for our list right now

Why it could be worth it

What to watch out for

See Health care stocks that passed both tests

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
past 12 months to June 2026
8.4%high

For every $100 of what the whole company costs, it produced $8.42 of spare cash in the past 12 months. A savings account pays about $4.

Price to profit
past 12 months to June 2026, without the one-off
35.1×full

You pay 35.1 years of operating profit for the business. The average large US company costs around 18.

Return on capital
five annual reports to December 2025
-10.0%five-year median

Each dollar kept in the business earns -10 cents a year. Above 10 is good.

Quality score: 40 of 100. Price score: 33 of 100. Our list needs 70 on quality and 60 on price.

$8.52 a share, at its 1-year low

Over the past year the price has ranged from $8.44 to $14.76.

Dividend: 5.7% a year

Paid every year for at least 5 years

Prices from Tuesday’s close (6 October).

Five years of cash, in billions

0.5
0.4
0.2
0.3
0.1
0.1
2021202220232024202512 monthsto Jun '26
Revenue
$4.2bn$3.9bn$4.0bn$3.8bn$3.7bn
Operating margin
14.4%-23.9%-2.1%-23.2%-11.5%
Debt to equity
0.420.510.641.101.74
Shares outstanding
0.21bn0.21bn0.20bn0.20bn0.20bn

Health checks

  • Free cash flow positive5 of 5 years
  • Accounting looks honest (Beneish)Nothing unusual
  • Financial strength (Piotroski)4 of 9
  • Profit backed by cash (accruals)No
  • Debt1.74× equity
  • Revenue growth, five yearsSlow, 2.0% a year
  • Buying back its own sharesYes, 7% fewer since 2021

The quarter to June 2026

How the business did, compared with the same quarter a year earlier.

  • Sales: $898 million last quarter, down 4% on a year ago.
  • Profit: $37 million, after a loss of $45 million a year ago.
  • It loses 9 cents on each $1 of sales, compared with 28 cents a year earlier.
  • Spare cash over the past 12 months: $143 million, up from $138 million.
  • 1% more shares than a year ago. Each share owns a bit less of the company.
  • Debt is $2 billion more than cash, about the same as a year ago.
  • Sales grew on a year ago in 2 of the last 4 quarters.
Sales by quarter
Sales by quarter
Quarter toAmount
September 2024$951m
December 2024$905m
March 2025$879m
June 2025$936m
September 2025$904m
December 2025$961m
March 2026$880m
June 2026$898m
Profit by quarter
Profit by quarter
Quarter toAmount
September 2024-$494m
December 2024-$430m
March 2025$20m
June 2025-$45m
September 2025-$427m
December 2025-$146m
March 2026-$10m
June 2026$37m

From the company's quarterly reports to the SEC.

Dates

Next results (estimated)
n/a
Last annual report (10-K)
26 February 2026
Next quarterly (estimated, 10-Q)
5 November 2026

Who owns it

9 long-term investors we follow own it, unchanged from 9 last quarter. 373 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

5 investors own more than 5%.

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

In the last 12 months, 9 insiders bought $2m of shares on the open market. 1 sold $915,708.

  • HOSEIN CLYDE
    Director
    Bought
    Date
    15 June 2026
    Shares
    6,500
    Price
    $9.99
    Value
    $64,935
  • Gladden Brian T
    Director
    Bought
    Date
    15 June 2026
    Shares
    9,985
    Price
    $10.02
    Value
    $100,050
  • MAZELSKY JONATHAN JAY
    Director
    Bought
    Date
    12 June 2026
    Shares
    10,000
    Price
    $10.14
    Value
    $101,400
  • MCKEON BRIAN P
    Director
    Bought
    Date
    12 June 2026
    Shares
    10,000
    Price
    $10.12
    Value
    $101,200
  • HOLDEN BETSY D
    Director
    Bought
    Date
    11 June 2026
    Shares
    10,086
    Price
    $9.88
    Value
    $99,650
  • Barber Michael J
    Director
    Bought
    Date
    11 June 2026
    Shares
    15,175
    Price
    $9.89
    Value
    $150,081
  • LUCIER GREGORY T
    Director
    Bought
    Date
    9 March 2026
    Shares
    15,000
    Price
    $12.45
    Value
    $186,750
  • Forbes James D
    Director
    Bought
    Date
    9 March 2026
    Shares
    5,000
    Price
    $12.48
    Value
    $62,400
  • LUCIER GREGORY T
    Director
    Bought
    Date
    3 March 2026
    Shares
    22,445
    Price
    $14.03
    Value
    $314,903
  • Forbes James D
    Director
    Bought
    Date
    3 March 2026
    Shares
    5,000
    Price
    $13.47
    Value
    $67,350

From Form 4 filings: insiders must report trades in their own company's shares within two days.

What could go wrong

  • Sales have barely grown: 2.0% a year.
  • It isn't cheap on profits: 35.1× operating profit.

Whether the price already reflects the risks is what the deep dive is for.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.